Effect of Different Lipid Ratios on Physicochemical Stability and Drug Release of Nanostructured Lipid Carriers Loaded Coenzyme Q10
Downloads
Background: For treatment or skin care via topical route, Coenzyme Q10 needs to permeate the epidermis which it is practically insoluble in water and a high molecular weight that make it difficult to penetrate the skin. Nanostructured Lipid Carriers (NLC) is chosen because of its ability to dissolve and solve the problem of low skin permeation. The type and ratio of solid and liquid lipids used in NLC affect the physicochemical characteristics, thus affecting the release profile and system stability. Objective: This study aimed to determine the effect of various ratios of Compritol 888 ATO as solid lipid and Miglyol 812 as liquid lipid on the physicochemical stability and Coenzyme Q10 release profile of NLC system. Methods: NLC was prepared using High Shear Homogenization method with three different lipid ratios. The ratio of Compritol 888 ATO : Miglyol 812 was 70:30, 80:20, and 90:10, respectively. NLC was evaluated for drug release and stability parameters including organoleptic, particle size, polydispersity index (PI), pH, viscosity, assay, and entrapment efficiency. Results: The stability test result for 90 days showed increments in the particle size and viscosity, whereas for assay and entrapment efficiency were decreased. The release test results showed no significant difference in the release parameters of the three tested formulas. Conclusion: During stability evaluation, NLC-CoQ10 systems did not significantly change pH and PI values, but statistically significantly changed particle size, viscosity, assay, and entrapment efficiency. The different in lipid ratios used in the formulas did not show significantly different results for release parameters.
Aburahma, M. H., & Badr-Eldin, S. M. (2014). Compritol 888 ATO: A multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opinion on Drug Delivery, 11(12), 1865–1883. https://doi.org/10.1517/17425247.2014.935335
Andarina, R., & Djauhari, T. (2017). Antioksidan dalam Dermatologi. Jurnal Kedokteran Dan Kesehatan, 4(1), 39–48.
Annisa, R., Hendradi, E., & Melani, D. (2016). Pengembangan sistem nanostructure lipid carriers (NLC) meloxicam dengan lipid monostearin dan Miglyol 808menggunakan metode emulsifikasi. Journal of Tropical Pharmacy and Chemistry, 3(3), 156–169.
Apostolou, M., Assi, S., Fatokun, A. A., & Khan, I. (2021). The effects of solid and liquid lipids on the physicochemical properties of nanostructured lipid carriers. Journal of Pharmaceutical Sciences, 110(8), 2859–2872. https://doi.org/10.1016/j.xphs.2021.04.012
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics, 10(2), 1–17. https://doi.org/10.3390/pharmaceutics10020057
Guedes, L. de S., Martinez, R. M., Bou-Chacra, N. A., Velasco, M. V. R., Rosado, C., & Baby, A. R. (2021). An overview on topical administration of carotenoids and coenzyme q10 loaded in lipid nanoparticles. Antioxidants, 10(7), 1–25. https://doi.org/10.3390/antiox10071034
Hendradi, E., Rosita, N., & Rahmadhanniar, E. (2017). Effect of lipid ratio of stearic acid and oleic acid on characteristics of nanostructure lipid carrier (NLC) system of diethylammonium diclofenac. Indonesian Journal of Pharmacy, 28(4), 198–204. https://doi.org/10.14499/indonesianjpharm28iss4pp198
Hernández-Camacho, J. D., Bernier, M., López-Lluch, G., & Navas, P. (2018). Coenzyme Q10 supplementation in aging and disease. Frontiers in Physiology, 9(FEB), 1–11. https://doi.org/10.3389/fphys.2018.00044
Nayak, K., Katiyar, S. S., Kushwah, V., & Jain, S. (2017). Coenzyme Q10 and retinaldehyde co-loaded nanostructured lipid carriers for efficacy evaluation in wrinkles. Journal of Drug Targeting, 26(4), 333–344. https://doi.org/10.1080/1061186X.2017.1379527
Nene, S., Shah, S., Rangaraj, N., Mehra, N. K., Singh, P. K., & Srivastava, S. (2021). Lipid based nanocarriers: A novel paradigm for topical antifungal therapy. Journal of Drug Delivery Science and Technology, 62(December 2020), 102397. https://doi.org/10.1016/j.jddst.2021.102397
Ortiz, A. C., Yañez, O., Salas-Huenuleo, E., & Morales, J. O. (2021). Development of a nanostructured lipid carrier (NLC) by a low-energy method, comparison of release kinetics and molecular dynamics simulation. Pharmaceutics, 13(4). https://doi.org/10.3390/pharmaceutics13040531
Prakash, C., Bhargave, P., Tiwari, S., Majumdar, B., & Bhargava, R. K. (2017). Skin surface pH in acne. Journal of Clinical and Aesthetic Dermatology, 10(7), 33–39.
Ryu, K. A., Park, P. J., Kim, S. B., Bin, B. H., Jang, D. J., & Kim, S. T. (2020). Topical delivery of coenzyme Q10-loaded microemulsion for skin regeneration. Pharmaceutics, 12(4). https://doi.org/10.3390/pharmaceutics12040332
Salt, A. (2021). A data set to verify volume and sample removal correction calculations for dissolution testing. Dissolution Technologies, 28(2), 16–20. https://doi.org/10.14227/DT280221P16
Salvi, V. R., & Pawar, P. (2019). Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology, 51(990), 255–267. https://doi.org/10.1016/j.jddst.2019.02.017
Sguizzato, M., Mariani, P., Spinozzi, F., Benedusi, M., Cervellati, F., Cortesi, R., Drechsler, M., Prieux, R., Valacchi, G., & Esposito, E. (2020). Ethosomes for coenzyme Q10 cutaneous administration: From design to 3D skin tissue evaluation. Antioxidants, 9(6). https://doi.org/10.3390/antiox9060485
United States Pharmacopoeia Convention. (2020). The United States Pharmacopoeia 43 and The National Formulary 38. Philadelphia: United States Pharacopoeia Convention Inc.
Copyright (c) 2023 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
